key: cord-0938396-wf7mhmgt
authors: Vandepitte, Sophie; Alleman, Tijs; Nopens, Ingmar; Baetens, Jan; Coenen, Samuel; De Smedt, Delphine
title: Cost-Effectiveness of Coronavirus Disease 2019 Policy Measures: A Systematic Review
date: 2021-09-30
journal: Value Health
DOI: 10.1016/j.jval.2021.05.013
sha: 51dac793f32c659c97a58fc78afc5a4c50bc3a71
doc_id: 938396
cord_uid: wf7mhmgt

OBJECTIVES: The coronavirus disease 2019 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of various coronavirus disease 2019 policy measures. METHODS: A systematic literature search was conducted in PubMed, Embase, and Web of Science. Health economic evaluations considering both costs and outcomes were included. Their quality was comprehensively assessed using the Consensus Health Economic Criteria checklist. Next, the quality of the epidemiological models was evaluated. RESULTS: A total of 3688 articles were identified (March 2021), of which 23 were included. The studies were heterogeneous with regard to methodological quality, contextual factors, strategies’ content, adopted perspective, applied models, and outcomes used. Overall, testing/screening, social distancing, personal protective equipment, quarantine/isolation, and hygienic measures were found to be cost-effective. Furthermore, the most optimal choice and combination of strategies depended on the reproduction number and context. With a rising reproduction number, extending the testing strategy and early implementation of combined multiple restriction measures are most efficient. CONCLUSIONS: The quality assessment highlighted numerous flaws and limitations in the study approaches; hence, their results should be interpreted with caution because the specific context (country, target group, etc) is a key driver for cost-effectiveness. Finally, including a societal perspective in future evaluations is key because this pandemic has an indirect impact on the onset and treatment of other conditions and on our global economy.

Since December 2019, the coronavirus disease 2019 (COVID- 19) pandemic has resulted in more than 128 million confirmed cases and caused more than 2.8 million deaths worldwide. 1 As a result of the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), national authorities around the world had to implement drastic policy measures-ranging from limiting social contact, mandating the use of face masks, shutting schools and nonessential business activities, banning of public gatherings, and closing country borders to a countrywide lockdown-to contain transmission of the virus with the ultimate aim to prevent a healthcare system collapse. 2, 3 Most countries were caught in speed; hence, limited evidence was available on the effectiveness and even more so on the cost-effectiveness of the different measures to flatten the infection curve. 4 Nevertheless, as time went by and because the pandemic continues to put pressure both on our healthcare system and our global economy, there is an urgent need for intelligent measures, that is, timely measures that can prevent our healthcare system from submerging in new COVID-19 waves; safeguard the physical, emotional and mental health, and well-being of the population; and protect risk groups. Nevertheless, to advise our decision makers in their decision-making process, up-to-date evidence is key. 5 In the last few months, there has been a rapid increase in the number of COVID-19-related publications. Hence, this study aimed to systematically review the available cost-effectiveness studies on different policy measures to protect, detect, prevent/contain, and treat COVID-19 infections and to assess their quality, strengths, and limitations. Our results can advise decision makers worldwide on the optimal trajectory of implementing COVID-19 interventions that provide best value for money and will guide researchers on the existing evidence gaps.

The methodology and reporting of this systematic review is consistent with the proposed methodology for systematic reviews of the Cochrane Collaboration. 6 

A systematic search for peer-reviewed health economic evaluations published up to March 2021 was performed in 3 electronic databases: Web of Science, PubMed, and Embase. The following key terms were used in the search strategy: "cost-effectiveness," "cost-benefit," "cost-utility," "health economic evaluation," "COVID-19," "corona," "COVID19," "COVID," and "SARS-CoV-2." In addition, reference lists of relevant articles were searched. The detailed search strategy is given in Appendix 1 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2021.05.013. Several inclusion criteria were formulated in advance (Table 1) .

A detailed overview of the study screening and selection is given in Figure 1 . Using a blinded web tool (Rayyan 7 ), 2 independent reviewers (S.V. and D.D.S.) searched for relevant studies on the basis of titles and abstracts. Next, the full texts of the remaining articles were reviewed independently. In case of noncorresponding results, consensus was sought between both reviewers.

The methodological quality of the included health economic evaluations was evaluated using the Consensus Health Economic Criteria (CHEC) checklist 8 designed for assessing the methodological quality of health economic evaluations to be used in systematic reviews. Each criterion of the CHEC was scored either yes (1) or no (0), yielding a total score between 0 and 19. Next, an independent expert (T.A.) evaluated the quality of the included epidemiological models. This reviewer paid particular attention to the disease dynamics and to good modeling practice. 9 

Overall, 23 articles were included in this systematic review (Fig. 1) . Nine studies originated from the United States, 3 from the United Kingdom, 2 from South Africa, 2 from China, 2 from Germany, 1 from Ghana, 1 from India, and 1 from Israel; 1 study considered a group of 139 low-and middle-income countries, and 1 study did not focus on a particular country. The target population included the general population (13 studies), homeless adults (1 study), students (2 studies), patients who did not have COVID- 19 (1 study), (hospitalized) patients with COVID-19 (4 studies), and healthcare workers (HCWs) (2 studies). Moreover, 5 studies focused on detection, 3 studies on protection, 12 studies on prevention/containment, and 3 studies on treatment. A comprehensive overview of the characteristics of the included articles can be consulted in Table 2 and in more detail in Appendix 2 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2021. 05.013.

The CHEC quality assessment was performed for each included study (see Appendix 3 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2021.05.013). Nine studies scored high (.13/19), [10] [11] [12] [13] [14] [15] [16] [17] [18] 10 studies scored moderate, [19] [20] [21] [22] [23] [24] [25] and 4 studies scored low (#6/19). 26, 27 

Of the 23 studies, 18 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] used a compartmental disease model to compute how SARS-CoV-2 spreads in the population. In contrast, 5 studies 28-32 combined different approaches such as decision trees and life-table models to model disease impacts. Of the 16 compartmental disease models, 13 used an extended version of the classical Susceptible-Exposed-Infectious-Recovered-Deceased model ( Table 2) . [10] [11] [12] [15] [16] [17] [18] [19] [20] [21] [24] [25] [26] Six studies 13, [16] [17] [18] 21, 26 calibrated their models using COVID-19 incidence data in an attempt to replicate and extrapolate a real-world epidemiological situation. In contrast, 12 studies [10] [11] [12] 14, 15, 19, 20, [22] [23] [24] [25] 27 set up hypothetical epidemiological situations.

Nine studies incorporated age stratification in their models, 10, 11, 15, 17, 18, 20, [24] [25] [26] [27] [28] [29] [30] [31] 12 studies incorporated presymptomatic infectiousness, [10] [11] [12] [13] [15] [16] [17] [18] [19] [20] 24, 25 15 studies incorporated asymptomatic COVID-19 infections, [10] [11] [12] [15] [16] [17] [18] [19] [20] [21] [22] [24] [25] [26] 30 and 14 studies [10] [11] [12] [13] [14] [15] 17, 18, 20, 22, 24, 25, 28, 29 incorporated differences in COVID-19 severity. Of the 16 compartmental disease models, 10 11,12,15-19,22,23,26 

Eighteen studies conducted a cost-effectiveness analysis, [10] [11] [12] [14] [15] [16] [17] [18] [19] 21, 22, 26, 27, 31, 32 5 performed a cost-benefit analysis, 13, 20, [23] [24] [25] and 1 discussed the budget impact alongside their costeffectiveness analysis 19 (Table 2 and Appendix 2 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2021.05. 013). The health outcomes used in the models were diverse: deaths/deaths averted, infections/infections averted, qualityadjusted life-years (QALYs), quality-adjusted life-days, life-years saved, and hospital days. Cost outcomes were reported in $ or local currencies. The reported willingness to pay (WTP) thresholds differed substantially across studies depending on the health outcome used and country-specific contextual factors. Four studies did not report on WTP. 22, 26, 27, 32 The time horizons (duration over which outcomes are projected) used in the studies ranged from 43 days to a lifetime with 5 studies not reporting on this aspect. 10, 20, 27, 29, 30 Costs and health outcomes were discounted in 6 studies. 10, 13, 16, 19, 28, 30 Only 12 studies explicitly reported on the perspective used. 11, [13] [14] [15] [16] [17] [18] [19] 22, 28, 29, 31 Eight of them used a healthcare payer perspective. 11, 13, 14, [16] [17] [18] 28, 31 Five studies built their models on the basis of a societal perspective. 13, 15, 19, 22, 31 Intervention costs related to protect, detect, and prevent/contain COVID-19 included costs of testing/screening, cost of quarantine/isolation, and cost of protective equipment, masks, and cleaning or disinfection. Disease and treatment costs accounted for the cost of the intervention and healthcare use including the costs of hospitalization days and intensive care unit (ICU) stay. Besides these direct costs, several studies included the cost of absenteeism (9 studies 10, 13, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 30, 32 ) or anticipated gross domestic product losses (4 studies 10, [23] [24] [25] .

Fourteen studies included multiple scenario analyses in their models, [10] [11] [12] [18] [19] [20] [25] [26] [27] [28] 32 11 conducted 1-way sensitivity analyses, 11, 13, 14, 16, 17, 20, 21, 23, [29] [30] [31] 2 performed 2-way sensitivity analyses, 11,30 2 performed multiway sensitivity analyses, 17,18 and 7 conducted probabilistic sensitivity analyses, 13, 14, 21, 22, 28, 30, 32 whereas 2 did not include any sensitivity analyses. 26, 27 In the different scenario and sensitivity analyses, different model parameters were varied, such as the virus reproduction number (R e ), WTP, specificity and sensitivity of tests, intervention adherence, number of exogenous shocks, contact rates, different lockdown durations, and cost of interventions.

Three studies 22, 30, 32 investigated the cost-effectiveness of protective measures for HCWs and concluded that personal protective equipment (PPE) can be cost-effective depending on the context.

Savitsky and Albright 30 focused on PPE compared with COVID-19 screening to protect HCWs from COVID-19 transmission on a labor and delivery hospital unit in a US setting. Distinction was made in delivery mode (spontaneous labor, induced labor, or cesarean section). They concluded that universal screening is the preferred strategy for spontaneous and induced labor, whereas for a planned cesarean section universal PPE is cost saving.

Ebigbo et al 32 compared 8 strategies related to testing and extensive PPE use (filtering facepiece-2 masks, goggles, and waterresistant gowns) for asymptomatic patients entering an At relatively low prevalence of disease (,10%), universal screening is the preferred strategy for women presenting in spontaneous labor and for labor induction. Interestingly for a planned CD universal PPE was more often cost-effective, and therefore, the preferred strategy as long as the cost of PPE remained stable. At high disease prevalence, universal PPE is the best strategy to protect HCW. 

Five studies calculated the cost-effectiveness of different detection strategies. 12, 16, [18] [19] [20] In general, testing is a cost-effective strategy and more extensive testing becomes more efficient with increasing R e .

Jiang et al 16 with COVID-19-consistent symptoms was the preferred (dominant) strategy. With a higher R e , PCR testing for all symptomatic persons and monthly PCR testing for the entire population was the most cost-effective strategy (ICER = $33 000/QALY) In line with Neilan et al, 18 Paltiel et al 12, 19 performed 2 studies in a US setting (2020 and 2021). In their first study, they focused on the cost-effectiveness of a screening strategy on a college campus, thereby comparing 4 different screening strategies with "doing nothing" going from daily to weekly screening, again using different R e and different test sensitivity values. They also concluded that, with higher R e , more frequent testing becomes the preferred strategy. In their second study, they investigated the cost-effectiveness of weekly home-based SARS-CoV-2 antigen testing compared with a no testing strategy, again using different R e (0.9, 1.3, 1.7, 2.8) whereby high-frequency home testing was considered cost-effective for all reproduction rates.

Du et al 20 compared 8 testing strategies using rapid antigen testing at different frequencies going from daily to monthly (every 1, 7, 14, and 28 days) followed by a 1-week or 2-week isolation period for confirmed cases assuming 2 different R e (1.2 and 2.2). Under high R e , weekly testing coupled with 2-week isolation for confirmed cases was preferred, assuming lower R e monthly testing with 1-week isolation was preferred.

A total of 12 studies assessed the cost-effectiveness of prevention or containment strategies of which 1 study was published twice 24,25 with a slightly different approach. 10, 11, [13] [14] [15] 17, 21, [23] [24] [25] [26] [27] Most of the studies combined multiple policy measures using various R e . In general, maintaining social distancing, undergoing quarantine/isolation, using a mask, using hygienic measures, and having movement restrictions was cost-effective. As R e increase, strategies should be adopted simultaneously and in a timely manner.

The studies by Miles et al 24, 25 assessed the cost-benefit of a 3-month lockdown in the United Kingdom compared with "doing nothing" on the basis of different gross domestic product loss assumptions and QALY loss assumptions. In the best case, the lockdown was associated with £68 billion loss, in the worst case with £547 billion loss. In their second study, they accounted for approximately £20 000 additional healthcare benefits for each death avoided through the lockdown; hence, the total damage decreased to £59 billion in the best case. 1) Awareness campaign to protect susceptible individuals from contacting the infected individuals in the same region 2) Security campaigns and health measures protecting and preventing susceptible individuals from contacting the infected individuals in the same region or in other regions 3) Protecting susceptible individuals, preventing their contact with the infected individuals, and encouraging the exposed individuals to join QCs 4) Protecting susceptible individuals, preventing their contact with the infected individuals, encouraging the exposed individuals to join quarantine centers, and the disposal of the infected animals SEIQRD with SI model for animals-susceptible (S), exposed (E), infectious (I), quarantined (Q) and recovered (R), (D) discrete time General population 1) National lockdown 1 Individuals who have essential occupations (as determined by government decisions) will not be quarantined and will be required to maintain social distancing. All known exposed individuals will be completely isolated for a 14-day period 2) Testing, tracing, isolation (focused isolation of individuals at high exposure risk who will return to the workforce under social distancing measures after a 14-day isolation period)

Extended SEIRD-(S) susceptible, (E) exposed, (Ia) asymptomatic, (Is) symptomatic and infectious, (R) recovered, (D) deceased Zala et al 10 compared 3 preventive strategies compared with doing nothing across the general population in the United Kingdom: (1) "Mitigation policy" including individual case isolation, home quarantine, and social distancing advice for people older than 70 years; (2) "Suppression strategy 1": a mitigation policy 1 general social distancing and closure of schools and universities that was triggered "on" when there were 100 ICU cases in a week and "off" when weekly cases halved to 50 cases; and (3) "Suppression strategy 2": the suppression strategy 1, this time triggered "on" when there were 400 ICU cases in a week and "off" when weekly ICU cases halved to 200 cases. Compared with the unmitigated and mitigated strategy, both suppression strategies 1 and 2 were cost-effective.

Zhao et al 13 Over time a strategy of national lockdown is moderately superior to a strategy of focused isolation in terms of reducing death rates but involves extremely high economic costs to prevent 1 case of death. A national lockdown has a moderate advantage in saving lives with tremendous costs and possible overwhelming economic effects. Asamoah et al 26 also considered a wide range of prevention strategies targeting the general population in Ghana whereby safety measures, such as proper cough etiquette were the preferred strategy over the following 5 other strategies: (1) testing and quarantine, (2) cleaning of surfaces, (3) using nose masks and face shields, (4) fumigating commercial areas, and (5) a combination of all, but the exact results were not clearly reported.

Reddy et al 17 also compared a range of strategies that were combined in a stepwise approach across the general population in South Africa assuming different R e : (1) testing, (2) 1 1 contact tracing, (3) 1 1 2 1 plus isolation center, (4) 1 1 2 1 3 1 plus mass symptom screening, (5) 1 1 2 1 3 1 plus quarantine center, and (6) 1 1 2 1 3 1  4 1 5. Assuming an R e of 1.2, strategy 5 was the most cost-effective strategy. Applying an R e of 1.5, combining all interventions was the most cost-effective strategy (ICER = $340/LY saved).

Khajji et al 27 also compared prevention strategies, again using a stepwise approach adding more restrictions in the general population ranging from awareness/security campaigns (to avoid contact with infected people) to joining quarantine centers whereby protecting susceptible individuals, preventing their contact with the infected individuals, and encouraging the exposed individuals to join quarantine centers were the preferred strategies.

Losina et al 15 considered 4 prevention/containment strategies among college students: social distancing, wearing a mask, isolation, and laboratory testing (going from no testing of asymptomatic students to routine laboratory testing of asymptomatic students at 14-, 7-, or 3-day intervals) in various combinations compared with campus closure and campus opening as usual (24 strategies in total). Extensive social distancing with mandatory use of a mask seemed to be the most cost-effective strategy ($49 200/QALY).

Baggett et al 11 compared 7 strategies in homeless US adults, including different combinations of symptom screening, PCR Extended SEIRD (CEACOV)-(S) susceptible, (E) exposed (latent, noninfectious), (Ip/Ia) pre-and asymptomatic, (Im) mildly infected, (Is) severely infected, (Ic) critically infected, (Ir) recuperation after critical infection, (R) recovered, and (D) deceased testing, nonhospital alternative care sites (ACSs), and relocating all shelter residents to temporary housing compared with doing nothing using different R e (0.9, 1.3, 2.6). Assuming an R e of 0.9 or R e of 1.3, daily symptom screening and ACSs for sheltered homeless adults was the preferred strategy. With a R e of 2.5, shelterbased universal PCR testing every 2 weeks for those without symptoms should be added. Bagepally et al 14 assessed the cost-effectiveness of the use of surgical mask with hand hygiene, hand hygiene alone, surgical mask alone, and N95 respirator (fit tested and nonfit tested) compared with doing nothing from an Indian perspective; none of the proposed interventions was cost-effective.

In contrast, Thunström et al 23 conducted a cost-benefit analysis by only comparing social distancing with no social distancing in a US context. They found that, in the base case, social distancing generates a net social benefit of $5.16 trillion.

Three studies investigated the cost-effectiveness of different treatment strategies. Sheinson et al 28 compared treatment in hospitalized patients with COVID-19 (no oxygen support, oxygen support without ventilation, oxygen support with ventilation) with supportive care; all ICERs (payer [bundled and fee for service payment] and societal perspective) were below the WTP = 50 000$/QALY and thus considered cost-effective. Cleary et al 29 analyzed the cost-effectiveness of intensive care management in South Africa, a country that experienced shortages of critical care capacity in public hospitals. With an ICER of ZAR 73 091/disabilityadjusted life-year averted, purchasing ICU capacity from the private sector was not cost-effective. In contrast, Gandjour 31 investigated the cost-effectiveness of expanding the ICU capacity in Germany, resulting in a cost-effective ICER of V21 958/life-year gained and a return on investment equal to 4.6. 

This systematic review summarizes the cost-effectiveness evidence of the different COVID-19 policy measures and provides a detailed overview of the quality, strengths, and limitations of these published studies. The ultimate goal of our healthcare system is to improve health. Nevertheless, because financial resources are scarce, we aim to produce as much health gain as possible with our restricted means. To do this, information on the "best buy" is extremely important. 33 This review can be used by decision makers worldwide to gain insight in the optimal trajectory of implementing timely interventions providing best value for money to tackle pandemics. Furthermore, it can also guide researchers on the existing evidence gaps and flaws when developing their own health economic evaluations in the future. On the basis of the results of this systematic review, several conclusions can be drawn about the cost-effectiveness of different policy measures. First, there is a consensus that testing is a costeffective strategy. 11, 12, 16, 18, 20, 30, 32 Moreover, the higher the R e , the more cost-effective frequent testing of the entire population becomes. 11, 12, 16, 18, 20 Second, PPE can be cost-effective 22, 30, 32 depending on the context and on the R e (higher R e , more cost-effective). Third, evidence indicated that undergoing quarantine, 10,20 using a mask, 15 and maintaining social distancing 10, 15, 23 are also efficient strategies to contain COVID-19. Fourth, 2 highquality studies indicated that with increasing R e , a combination of restrictive measures (from testing, social distancing, and quarantine to closures) together is most efficient in tackling this crisis. 10, 17 Even more, another study also pointed out the importance of early implementation of movement restrictions compared with a delayed response. 13 Next, according to 3 studies, the high economic societal cost of lockdown did not outweigh the health benefits; however, none of these studies accounted for the potential health consequences of a healthcare system collapse. 21, 24, 25 Comparison across studies is challenging and should be done with caution, not only because of contextual differences but also because of methodological variation, such as the use of different health outcomes, variation in included costs, and the differences in methodological quality. Indeed, the quality appraisal indicated that the current health economic evaluations are plagued by several methodological issues. A major limitation is the high uncertainty and preliminary nature of most input parameters because of the sparsity of available COVID-19 data. 10, 16, 22, 30 Because many health and economic consequences are not yet known, correctness of the evaluations highly depends on the accuracy of the projections and assumptions made by the used epidemiologic models. 10 In addition, many studies had generalizability issues because studies were often very context specific. Moreover, future healthcare costs and health effects that were directly related to the pandemic were often not accounted for. Indeed, Savitsky and Albright 30 24, 25 ) and only included nondetailed short-term direct healthcare cost consequences. 16 Furthermore, most studies did not report on potential side effects, such as the economic impact, the mental health impact, and educational regression of the different strategies investigated or only did so for a particular intervention instead of for all usual care. Another barrier was the lack of data on acceptability among the population and the variable uptake of containment measures. Furthermore, some studies lacked the basic knowledge of health economic evaluations, such as the proper calculation of ICERs. As such, 3 studies reported negative ICERs without computing incremental effects. 26, 27, 32 In addition, several studies 16, 22, 26, 27, 30 experienced a lack of transparency about the included costs and their data source. Next, several shortcomings of the epidemiological models used in the evaluations should be addressed. Many studies assumed homogeneous population mixing of large and spatially heterogeneous territories or have used nonage-dependent disease characteristics. Both are drastic simplifications of reality that result in an overestimation of COVID-19 prevalence. 18, 19 Others did not include a mathematical model description, [16] [17] [18] [23] [24] [25] [26] [27] [28] [29] [30] an overview of the chosen disease parameters, 16, 22, 27 or a flowchart of the disease model compartments, which compromised reproducibility and tangibility of the disease model. 22 Finally, this systematic review itself has several limitations as well. First, because the literature on COVID-19 evolves very fast, this systematic search should be updated regularly to include new evidence. As such, this systematic review updates the review of Rezapour et al 34 which included articles until July 2020. 34 Nevertheless, their review used a slightly different approach by including many nonpeerreviewed articles. Despite the potential loss of high-quality articles, the authors are convinced that the current approach is preferred because a peer review process assures a minimum level of quality, which is of particular importance in this crisis because of the rapid spread of poor quality publications.

On the basis of the main findings of this review, several recommendations can be formulated. First, the findings mentioned above call for a "triggered" stepwise approach, where policy makers should timely shift from one strategy to another on the basis of predefined thresholds. Moreover, it is also important to prevent delay in implementing those "shifts." Second, future research should deal with the current methodological problems in this field. As such, adopting a broad societal perspective is key, not only considering short-and long-term COVID-19 health losses and costs but also other health losses and costs associated with untreated chronic diseases because of limited healthcare capacity, Extending the existing ICU bed capacity seems acceptable on the basis of the MCER but also from a budgetary perspective. That is, extending capacity by more than 100% is forecast to result in a one-time increase in healthcare expenditure of 13%. If, however, the additional capacity remains entirely unused, the value of the investment becomes negative because of the presence of fixed costs. Nevertheless, it is reassuring that even a vacancy rate of 98% still allows for a positive return because of the low share of infrastructure costs. This is equivalent to a 2% probability of having full utilization. 6 the broader economic impact, mental health losses because of social and material deprivation, and educational regression. 33, 35 Third, it is unfortunate that none of the evaluations focused on how a healthier lifestyle could protect against severe COVID-19 outcomes. In this light, cost-effectiveness of lifestyle strategies should also be investigated. 36 Fourth, because each country has different characteristics and societal challenges, such as a different population density, a different population structure (more elderly population in western countries), differences in healthcare system capacity, or cultural differences, local policy makers must never blindly adopt containment measures from other countries. 37 Fifth, best modeling practices should be adopted in future studies, such as providing a complete mathematical description of the disease model and its parameters, demonstrating goodness-of-fit and confidence bounds when the model is calibrated to data, and demonstrating the tangibility of the epidemic growth scenarios, including sensitivity analyses to test robustness of the models and at the same time transparent reporting on included strategies. As such, existing models can be further adapted by others to model particular context-specific factors.

Future cost-effectiveness analyses should respect good modeling practices and should adopt a broad societal perspective considering: long-term COVID-19 health impact, health losses and costs associated with untreated chronic diseases because of limited healthcare capacity, the broader economic impact, mental health losses because of social and material deprivation, and educational regression. Meanwhile, stepwise and timely extending the testing strategy and implementing multiple restriction measures seem most cost-effective to mitigate rising SARS-CoV-2 spread.

) exposed (latent, noninfectious), (Ip/Ia) pre-and asymptomatic, (Im) mildly infected, (Is) severely infected, (Ic) critically infected, (Ir) recuperation after critical infection

Article and Author Information Accepted for Publication

Author Affiliations: Faculty of Medicine and Health Sciences, Department of Public Health and Primary Care

Email: sophie.vandepitte@ ugent.be Author Contributions: Concept and design: Vandepitte, De Smedt Acquisition of data: Vandepitte, De Smedt Analysis and interpretation of data: Vandepitte, Alleman, Nopens, Baetens, Coenen, De Smedt Drafting of the manuscript: Vandepitte, Alleman, Coenen, De Smedt Critical revision of the paper for important intellectual content: Vandepitte, Alleman, Nopens, Baetens, Coenen, De Smedt Administrative, technical, or logistic support: Vandepitte, Nopens Supervision: Nopens, Baetens, De Smedt REFERENCES 1. Weekly epidemiological update

Governmental measures database. ECML Covid, European Commission

Covid-19: how a virus is turning the world upside down

Containment strategies for the 2019 Novel coronavirus: flatten the curve or crush it?

The role of health economics and outcomes research in addressing coronavirus disease 2019 (COVID-19). Value Health

The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care

Rayyan-a web and mobile app for systematic reviews

Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria

Good Modelling Practice Handbook

Costing the COVID-19 pandemic: an exploratory economic evaluation of hypothetical suppression policy in the UK. Value Health

Clinical outcomes, costs, and cost-effectiveness of strategies for adults experiencing sheltered homelessness during the COVID-19 pandemic

Clinical and economic effects of widespread rapid testing to decrease SARS-CoV-2 transmission

Disease burden attributable to the first wave of COVID-19 in China and the effect of timing on the cost-effectiveness of movement restriction policies

Costeffectiveness of surgical mask, N-95 respirator, hand-hygiene and surgical mask with hand hygiene in the prevention of COVID-19

College campuses and COVID-19 mitigation: clinical and economic value

The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from the epidemic in Wuhan, China

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa

Clinical impact, costs, and cost-effectiveness of expanded SARS-CoV-2 testing in Massachusetts

Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States

Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study

Modeling social distancing strategies to prevent SARS-CoV-2 spread in Israel: a cost-effectiveness analysis

Costeffectiveness and return on investment of protecting health workers in lowand middle-income countries during the COVID-19 pandemic

The benefits and costs of using social distancing to flatten the curve for COVID-19

Stay at home, protect the National Health Service, save lives": a cost benefit analysis of the lockdown in the United Kingdom

Living with covid-19: balancing costs against benefits in the face of the virus

Global stability and cost-effectiveness analysis of COVID-19 considering the impact of the environment: using data from Ghana

A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control

A cost-effectiveness framework for COVID-19 treatments for hospitalized patients in the United States

Costeffectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa

Preventing COVID-19 transmission on labor and delivery: a decision analysis

How many intensive care beds are justifiable for hospital pandemic preparedness? A cost-effectiveness analysis for COVID-19 in Germany. Appl Health Econ Health Policy

Cost-effectiveness analysis of SARS-CoV-2 infection prevention strategies including pre-endoscopic virus testing and use of high risk personal protective equipment

Impact of COVID-19 pandemic on mental health in the general population: a systematic review

Economic evaluation of programs against COVID-19: a systematic review

Psychological impact and associated factors during the initial stage of the coronavirus (COVID-19) pandemic among the general population in Spain

Obesity and COVID-19 severity in a designated hospital in Shenzhen

Dynamic analysis of a mathematical model with health care capacity for COVID-19 pandemic

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. London: Imperial College

Conflict of Interest Disclosures: The authors reported no conflict of interest.Funding/Support: The authors received no financial support for this research.